Axogen Inc
AXGNBuild a strategy around AXGN
Axogen Inc AI Insights
Informational only. Not investment advice.Snapshot
- Gross margin 74.8% TTM vs industry median 41.6% - premium pricing power in nerve repair niche with 1.8x advantage[Gross Margin TTM]
- Revenue 3Y CAGR 17.6% vs industry 0.8% - 22x faster growth while reaching operating profitability (1.8% margin TTM)[Total Revenue 3Y Growth]
- P/S 7.2x vs industry median 3.0x with negative EPS (-$0.09 TTM) - priced for continued growth execution[P/S Ratio]
Watch Triggers
- Operating Margin TTM: Sustains above 5% for 2+ quarters — Confirms operating leverage thesis; current 1.8% is breakeven territory
- Total Revenue 3Y Growth: Falls below 10% — Growth deceleration invalidates premium valuation; P/S 7.2x requires 15%+ growth
- Interest Expense TTM: Exceeds operating income — Currently $7.8M vs $3.9M op income - already consuming 2x; refinancing risk
Bull Case
Specialty medical device with 75% gross margins in nerve repair - limited competition enables pricing power. 17.6% 3Y revenue CAGR demonstrates market adoption.
Just crossed profitability threshold with $3.9M operating income TTM. Fixed cost base means incremental revenue drops to bottom line at high rate.
Bear Case
Valuation demands perfection: P/S 7.2x (2.4x industry), P/B 13.5x, P/CF 237x. Any growth stumble severely punishes stock.
Debt/equity 0.56x with $7.8M interest expense TTM consuming most of $3.9M operating income. Thin margin for error.
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
Leverage AXGN's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
Operating leverage inflection: path to sustained profitability as revenue scales past fixed cost base
- Operating income turned positive at $3.9M TTM
- R&D 12.7% of revenue - leverage as sales grow
- Gross margin stable at 75% provides cushion
Valuation Context
Caveats
Public Strategies Rankings
See how Axogen Inc ranks across different investment strategies.
Leverage AXGN's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.
AXGN Fundamentals
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$1.44B | — | ||
$1.47B | — | ||
0.00 | — | ||
$225.21M | +20.2% | — | |
$-0.34 | — | ||
-3.49% | -1.7% | — | |
-6.97% | -1.7% | — | |
$-4.78M | — | ||
-13.5% | -3.5% | — | |
Beta 5Y (Monthly) | unknown | — |
AXGN Dividend History
AXGN Stock Splits
AXGN SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
02/24/26 | 12/31/25 | 10-K | |
10/29/25 | 09/30/25 | 10-Q | |
08/05/25 | 06/30/25 | 10-Q | |
05/08/25 | 03/31/25 | 10-Q | |
02/26/25 | 12/31/24 | Unknown | |
11/07/24 | 09/30/24 | 10-Q | |
08/08/24 | 06/30/24 | 10-Q | |
05/02/24 | 03/31/24 | 10-Q | |
03/05/24 | 12/31/23 | 10-K | |
11/07/23 | 09/30/23 | 10-Q | |
08/08/23 | 06/30/23 | 10-Q | |
05/09/23 | 03/31/23 | 10-Q | |
03/14/23 | 12/31/22 | 10-K | |
11/08/22 | 09/30/22 | 10-Q | |
08/05/22 | 06/30/22 | 10-Q | |
05/05/22 | 03/31/22 | 10-Q | |
02/25/22 | 12/31/21 | 10-K | |
11/04/21 | 09/30/21 | 10-Q | |
08/05/21 | 06/30/21 | 10-Q | |
05/06/21 | 03/31/21 | 10-Q | |
03/01/21 | 12/31/20 | 10-K | |
10/30/20 | 09/30/20 | 10-Q | |
08/10/20 | 06/30/20 | 10-Q | |
05/06/20 | 03/31/20 | 10-Q | |
02/24/20 | 12/31/19 | 10-K | |
11/06/19 | 09/30/19 | 10-Q | |
08/06/19 | 06/30/19 | 10-Q | |
05/08/19 | 03/31/19 | 10-Q | |
02/26/19 | 12/31/18 | 10-K | |
10/29/18 | 09/30/18 | 10-Q | |
08/01/18 | 06/30/18 | 10-Q | |
04/30/18 | 03/31/18 | 10-Q | |
02/28/18 | 12/31/17 | 10-K | |
11/01/17 | 09/30/17 | 10-Q | |
08/02/17 | 06/30/17 | 10-Q | |
05/04/17 | 03/31/17 | 10-Q | |
03/01/17 | 12/31/16 | 10-K | |
11/02/16 | 09/30/16 | 10-Q | |
08/03/16 | 06/30/16 | 10-Q | |
05/04/16 | 03/31/16 | 10-Q | |
02/29/16 | 12/31/15 | 10-K | |
11/05/15 | 09/30/15 | 10-Q | |
08/06/15 | 06/30/15 | 10-Q | |
05/05/15 | 03/31/15 | 10-Q | |
03/05/15 | 12/31/14 | 10-K | |
11/13/14 | 09/30/14 | 10-Q | |
08/04/14 | 06/30/14 | 10-Q | |
04/30/14 | 03/31/14 | 10-Q | |
03/06/14 | 12/31/13 | 10-K | |
10/30/13 | 09/30/13 | 10-Q | |
08/14/13 | 06/30/13 | 10-Q | |
04/30/13 | 03/31/13 | 10-Q | |
03/12/13 | 12/31/12 | 10-K | |
11/06/12 | 09/30/12 | 10-Q | |
08/14/12 | 06/30/12 | 10-Q | |
05/15/12 | 03/31/12 | 10-Q | |
03/15/12 | 12/31/11 | 10-K | |
08/07/13 | 12/31/11 | 10-K/A | |
11/14/11 | 09/30/11 | 10-Q | |
08/11/11 | 06/30/11 | 10-Q | |
05/17/11 | 03/31/11 | 10-Q | |
03/30/11 | 12/31/10 | 10-K | |
11/15/10 | 09/30/10 | 10-Q | |
08/16/10 | 06/30/10 | 10-Q | |
05/17/10 | 03/31/10 | 10-Q | |
03/31/10 | 12/31/09 | 10-K | |
11/16/09 | 09/30/09 | 10-Q | |
08/13/09 | 06/30/09 | 10-Q | |
05/14/09 | 03/30/09 | 10-Q | |
03/31/09 | 12/31/08 | 10-K | |
11/19/08 | 09/30/08 | NT 10-Q | |
08/14/08 | 06/30/08 | 10-Q | |
03/31/08 | 03/30/08 | Unknown | -- |
12/31/07 | 12/31/07 | NT 10-K | |
09/30/07 | 09/30/07 | 10QSB | |
06/30/07 | 06/30/07 | 10QSB | |
03/31/07 | 03/30/07 | Unknown | -- |
12/31/06 | 12/31/06 | 10KSB | |
09/30/06 | 09/30/06 | 10QSB | |
06/30/06 | 06/30/06 | 10QSB | |
03/31/06 | 03/30/06 | Unknown | -- |
12/31/05 | 12/31/05 | 10KSB | |
09/30/05 | 09/30/05 | 10QSB | |
06/30/05 | 06/30/05 | 10QSB | |
03/31/05 | 03/30/05 | Unknown | -- |
12/31/04 | 12/31/04 | NT 10-K | |
09/30/04 | 09/30/04 | DEF 14A | |
06/30/04 | 06/30/04 | 10QSB | |
03/31/04 | 03/30/04 | Unknown | -- |
12/31/03 | 12/31/03 | 10KSB | |
11/19/03 | 09/30/03 | NT 10-Q | |
08/12/03 | 06/30/03 | 10-Q | |
05/14/03 | 03/30/03 | Unknown | -- |
04/14/03 | 12/31/02 | NT 10-K | |
11/14/02 | 09/30/02 | 10-Q | |
08/14/02 | 06/30/02 | 10-Q | |
05/15/02 | 03/30/02 | Unknown | -- |
11/14/01 | 09/30/01 | 10-Q | |
09/28/01 | 06/30/01 | 10-K | |
05/15/01 | 03/30/01 | Unknown | -- |
02/14/01 | 12/31/00 | 10-Q | |
11/14/00 | 09/30/00 | 10-Q | |
09/28/00 | 06/30/00 | 10-K | |
05/15/00 | 03/30/00 | Unknown | -- |